Glioblastoma (GBM) is the most prevalent and deadly primary brain tumor type, with a
discouragingly low survival rate and few effective treatments. An important function of the …

Glioblastoma multiforme (GBM) is an aggressive primary brain tumor characterized by
extensive heterogeneity and vascular proliferation. Hypoxic conditions in the tissue …

Glioblastoma multiforme (GBM), a highly aggressive tumor of the central nervous system, is
the most common malignant brain tumor and poses a significant risk to life. GBM patients …

Glioblastoma multiforme (GBM), a WHO grade 4 glioma, is the most common and
aggressive primary brain tumor, characterized by rapid progression and poor prognosis. The …

Despite decades of basic and clinical research and trials of promising new therapies, cancer
remains a major cause of morbidity and mortality due to the emergence of drug resistance to …

This study develops a skin-penetrating drug delivery system of thiolated chitosan-lithocholic
acid nanomicelles for the treatment of melanoma. In this regard, ergotamine was selected as …

Glioblastoma multiforme (GBM) remains one of the most aggressive and lethal forms of brain
cancer, characterized by rapid proliferation and diffuse infiltration into the surrounding brain …

Background Glioblastoma multiforme (GBM) is the most aggressive and prevalent type of
malignant brain tumor, yet it metastasizes outside the central nervous system (CNS) in 0.4 …

Glioma is a highly proliferative and aggressive tumor type that arises from glial cells in the
central nervous system. The nucleotides required for the proliferation and replication of …

Glioblastoma multiforme (GBM) is recognized as a highly aggressive brain tumor, exhibiting
profound resistance to temozolomide (TMZ) chemotherapy. While methylation of the MGMT …